Product Performance of

Contraceptives:
Pre, During, and Post Covid Era
Outline
• Introduction
• Product Details
• Product Market Type
• Pricing Strategies of the Product
• Product Performance: Pre, During, and Post Covid Era
• Conclusion
Introduction
• Background information on the topic of contraceptives
• Importance of assessing product performance in the pre, during, and
post-Covid era
• Overview of the presentation structure
• Objectives of the presentation
Product Details
• Types of contraceptives available in the market
• Key features and benefits of contraceptives
• Regulatory requirements and certifications for contraceptives
• Technological advancements in contraceptive products
Product Market Type
• Market segmentation for contraceptives
• Target audience and consumer behavior analysis
• Competitive landscape and market share analysis
• Opportunities and challenges in the contraceptive market
Pricing Strategies of the Product
• Factors influencing pricing decisions for contraceptives
• Pricing models and strategies used in the industry
• Pricing considerations during the Covid-19 pandemic
• Impact of pricing on product performance and market positioning
How has the performance of contraceptives been
impacted during the pre, during, and post Covid era?
Pre-Covid Era
• In the pre-COVID era, access to contraception was relatively easier,
and unintended pregnancy rates were likely lower compared to the
pandemic period.
• Contraceptives were widely available through various channels,
including clinics, pharmacies, and online platforms.
• People had the freedom to choose from a range of contraceptive
methods, such as birth control pills, condoms, intrauterine devices
(IUDs), and implants.
• This accessibility and variety of options contributed to better family
planning and reduced unintended pregnancies.
During Covid :
• The COVID-19 pandemic posed several challenges to contraceptive
access and led to an increase in unintended pregnancy rates.
• The implementation of lockdowns and restrictions limited people's ability
to visit healthcare facilities, causing disruptions in the supply chain and
reduced availability of contraceptives.
• Many clinics and healthcare providers shifted their focus towards
COVID-19 response, resulting in reduced contraceptive services and
counseling.
• Additionally, financial constraints and fear of exposure to the virus
further hindered individuals from accessing contraceptives, leading to a
rise in unintended pregnancies during this period.
Post-Covid Era
• After the pandemic, the contraceptives industry has experienced certain
improvements.
• The increased awareness about reproductive health and family planning during
the COVID-19 pandemic has led to a greater demand for contraceptives.
• Additionally, there has been a shift towards telemedicine and online platforms
for accessing contraceptives, ensuring continued access to reproductive
healthcare during times of restricted movement.
• The industry has also witnessed innovations in contraceptive methods,
including long-acting reversible contraceptives (LARCs) such as intrauterine
devices (IUDs) and implants, which offer convenience and effectiveness.
• These advancements have contributed to the overall improvement of the
contraceptives industry post-pandemic.
Conclusion
• In conclusion, the product performance of contraceptives highlights
the significant impact of the pandemic on contraceptive usage and the
challenges faced by the industry.
• Importance of contraceptives.
• Problems during the pandemic.
• Measures to solve those problems.
• Improvement in the contraceptives industry
• Swayam Bhosale- Seat no. 31010723059- roll no. 23-7105
• Krish Shetty- Seat no. – roll no.
• Yash Kaushik – Seat no. – roll no.
• Dipanshu Ghosh- Seat no. – roll no.
• Nemil Doshi – Seat no. – roll no.
• Vedanth Bhat – Seat no. – roll no.
• Durgesh – seat no. – roll no.